Gå til søkefunksjon Gå til innhold

Du må bruke en annen nettleser. For å bruke våre webtjenester kan du isteden bytte til en av disse nettleserne: Apple Safari, Google Chrome, Microsoft Edge eller Mozilla Firefox. Les mer om anbefalte nettlesere.

SEB Fund 3 - SEB Medical Fund will merge with SEB Concept Biotechnology 

The management company, SEB Investment Management, has decided to merge SEB Fund 3 - SEB Medical Fund with SEB Concept Biotechnology, the receiving fund. The merger will be carried out 21 April 2023.  

The merging sub-fund has experienced a continued weak investment interest in recent years and asset under management in the fund continues to be low. The reason for the merger is to provide the benefit of a larger fund size which would result in greater efficiency from a portfolio management, operational, and cost-effective perspective. 

Click on the links below for complete information in English and Swedish.

English: sebgroup.lu

Swedish: seb.se